Insider screener

Period: 12 months Plan: Scheduled (10b5-1) × + Add filter Clear all
Saved screens

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

23,187 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

23,187 decisions over 12 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

23,187 decisions over 12 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

23,187 decisions over 12 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
23,187 decisions over 12 months Remove this filter
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
23,187 decisions over 12 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

23,187 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
5 Jan 2026
Bought on a plan
$27.43K 775 at 35.39
4.8%
Bought on a plan
5 Jan 2026
Jan Malcolm Director
Sold on a plan
$24.75K 50 at 495.01
11.9%
Planned (10b5-1)
5 Jan 2026
Joseph Sanborn Chief Financial Officer
Sold on a plan 2×
$24.67K 1,063 at 23.21
0.4%
Planned (10b5-1)
5 Jan 2026
Sold on a plan
$23.93K 130 at 184.10
8.4%
Planned (10b5-1)
5 Jan 2026
Sold on a plan
$23.24K 136 at 170.89
0.6%
Planned (10b5-1)
5 Jan 2026
Sold on a plan
$21.53K 126 at 170.89
0.9%
Planned (10b5-1)
5 Jan 2026
Jennifer Ladd Hanson Chief People Officer
Sold on a plan
$19.58K 524 at 37.36
1.0%
Planned (10b5-1)
5 Jan 2026
Jon Ayotte Chief Accounting Officer
Sold on a plan
$16.98K 675 at 25.16
1.2%
Planned (10b5-1)
5 Jan 2026
Harold Bernstein President, R&D & CMO
Sold on a plan
$16.48K 412 at 40.00
100%
Sold half or more
5 Jan 2026
Luke Evnin Director · indirect
Sold on a plan
$11.76K 18,378 at 0.64
0.7%
Planned (10b5-1)
5 Jan 2026
Reuven Spiegel Executive Vice President, DKL
Sold on a plan
$11.75K 250 at 46.99
1.1%
Planned (10b5-1)
5 Jan 2026
Timothy G. Yarbrough EVP, Chief Financial Officer · indirect
Sold on a plan
$11.20K 3,035 at 3.69
4.2%
Planned (10b5-1)
5 Jan 2026
William O'Dowd IV Chief Executive Officer
Bought on a plan
$4.87K 3,000 at 1.62
0.7%
Bought on a plan
2 Jan 2026
Reed Hastings Director
Sold on a plan 4×
$39.08M 426,290 at 91.67
99.1%
Sold half or more
2 Jan 2026
Adena T Friedman Chair and CEO
Sold on a plan
$28.92M 300,000 at 96.39
13.5%
Planned (10b5-1)
2 Jan 2026
James R Murdoch Director · indirect
Sold on a plan 22×
$26.72M 60,000 at 445.40
9.4%
Planned (10b5-1)
2 Jan 2026
David A Duffield 10% owner
Sold on a plan 12×
$16.73M 81,479 at 205.29
43.7%
Planned (10b5-1)
2 Jan 2026
Bought on a plan
$16.49M 237,734 at 69.35
0.5%
Bought on a plan
2 Jan 2026
Orlov S Nicole Schaeffer Chief People Strategy Officer
Sold on a plan 5×
$15.29M 87,290 at 175.20
67.6%
Sold half or more
2 Jan 2026
Donald F Robertson Jr Principal Accounting Officer
Sold on a plan 5×
$15.19M 80,000 at 189.85
18.7%
Planned (10b5-1)
2 Jan 2026
Michael L Speiser Director · indirect
Sold on a plan 12×
$11.13M 50,338 at 221.16
61.2%
Sold half or more
2 Jan 2026
Stanley Tang Director · indirect
Sold on a plan 9×
$10.11M 45,410 at 222.53
100%
Sold half or more
2 Jan 2026
Frank Klein Chief Operations Officer
Sold on a plan 9×
$7.29M 100,000 at 72.95
7.9%
Planned (10b5-1)
2 Jan 2026
Andy Fang Director · indirect
Sold on a plan 9×
$6.68M 30,000 at 222.52
100%
Sold half or more
2 Jan 2026
Sold on a plan 9×
$5.71M 20,000 at 285.56
4.4%
Planned (10b5-1)
2 Jan 2026
Mark W. Jenkins Chief Financial Officer
Sold on a plan 25×
$5.14M 12,750 at 403.02
5.9%
Planned (10b5-1)
2 Jan 2026
Josh Silverman Director
Sold on a plan 3×
$4.98M 86,666 at 57.46
48.9%
Planned (10b5-1)
2 Jan 2026
Beth Ann Costello EVP and CFO
Sold on a plan 2×
$4.83M 35,339 at 136.58
31.3%
Planned (10b5-1)
2 Jan 2026
Frederic Simon Director
Sold on a plan 6×
$4.76M 80,000 at 59.51
2.1%
Planned (10b5-1)
2 Jan 2026
Mark T Mondello Executive Chairman
Sold on a plan 7×
$4.72M 20,000 at 236.25
1.7%
Planned (10b5-1)
2 Jan 2026
Anthony P Lee Director · indirect
Sold on a plan 9×
$4.72M 59,000 at 79.96
18.7%
Planned (10b5-1)
2 Jan 2026
Chi Fung Cheng Chief Technology Officer · indirect
Sold on a plan 9×
$4.31M 30,000 at 143.61
0.5%
Planned (10b5-1)
2 Jan 2026
Paul A Mahon EVP & General Counsel
Sold on a plan 8×
$4.03M 8,300 at 485.43
18.4%
Planned (10b5-1)
2 Jan 2026
Benjamin E. Huston Chief Operating Officer
Sold on a plan 24×
$4.02M 10,000 at 401.94
9.1%
Planned (10b5-1)
2 Jan 2026
Douglas H. Shulman President & CEO
Sold on a plan 3×
$3.93M 57,500 at 68.41
24.8%
Planned (10b5-1)
2 Jan 2026
Kate Gulliver CFO and Chief Admin Officer
Sold on a plan
$3.89M 36,497 at 106.50
19.7%
Planned (10b5-1)
2 Jan 2026
Ryan McInerney Chief Executive Officer
Sold on a plan
$3.66M 10,485 at 349.18
52.7%
Sold half or more
2 Jan 2026
Sold on a plan 13×
$3.46M 20,000 at 172.98
1.6%
Planned (10b5-1)
2 Jan 2026
Thomas J Wilson Chairman, President & CEO
Sold on a plan 4×
$3.44M 16,807 at 204.77
13.1%
Planned (10b5-1)
2 Jan 2026
William L Meaney President and CEO
Sold on a plan 2×
$3.20M 38,482 at 83.17
100%
Sold half or more
2 Jan 2026
Theodore Blegen EVP and CFO
Sold on a plan 15×
$2.82M 3,000 at 940.47
4.2%
Planned (10b5-1)
2 Jan 2026
Ishbia Mat President and CEO · indirect
Sold on a plan
$2.80M 632,874 at 4.42
9.1%
Planned (10b5-1)
2 Jan 2026
Vincent Roche Chair & CEO
Sold on a plan
$2.75M 10,000 at 275.07
6.0%
Planned (10b5-1)
2 Jan 2026
Jennifer Wuamett EVP & General Counsel
Sold on a plan 2×
$2.75M 12,425 at 220.94
51.3%
Sold half or more
2 Jan 2026
Jeffrey W Martin Chairman, CEO and President
Sold on a plan 2×
$2.68M 30,000 at 89.29
56.5%
Sold half or more
2 Jan 2026
Terrance P. Coyne EVP & CFO · indirect
Sold on a plan 2×
$2.67M 69,582 at 38.42
63.6%
Sold half or more
2 Jan 2026
David Malcom Rodman Chief Medical Officer
Sold on a plan
$2.51M 70,037 at 35.87
50.3%
Sold half or more
Showing 19,351–19,400 of 23,187. ← Newer Page 388 of 464 Older →